Immunogenicity of Nonavalent HPV Vaccine Administered Prior to Renal Transplantation in Adult Women: A Prospective, Single-Arm, Multi-Center Clinical Trial
Phase of Trial: Phase II
Latest Information Update: 04 Jul 2018
At a glance
- Drugs Human papillomavirus vaccine recombinant nonavalent Merck (Primary)
- Indications Cancer; Genital warts; Human papillomavirus infections
- Focus Therapeutic Use
- 31 May 2018 Planned primary completion date changed from 1 Jan 2020 to 1 Feb 2020.
- 28 Jun 2017 Planned primary completion date changed from 1 Feb 2020 to 1 Jan 2020.
- 28 Jun 2017 Status changed from not yet recruiting to recruiting.